EW | Edwards Lifesciences Corporation Stock Overview

(Stock Exchange: NYSE)

Day's Range	70.33 - 72.74
52 Week Range	58.93 - 95.73
Beta	1.12
Implied Volatility	35.21%
IV Rank	58.91%
Day's Volume	3,838,232
Average Volume	4,547,405
Shares Outstanding	585,755,000
Market Cap	42,455,522,400
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2000-03-27

Valuation
Profitability
Growth
Health
P/E Ratio	30.97
Forward P/E Ratio	47.62
EPS	2.34
1YR Price Target	131.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	19,800
Country	USA
Website	EW

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery.

EW's peers: ALGN, BSX, DXCM, MDT, ABT, ZBH, SYK, PODD, TNDM, INMD, MASS, NNOX, PHG, SENS

*Chart delayed

Analyzing fundamentals for EW we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is very good and Health is confidently strong. For more detailed analysis please see EW Fundamentals page.

Watching at EW technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on EW Technicals page.